Term Name: rolapitant hydrochloride hydrate
Synonyms: (5S,8S)-8-(((1R)-1-(3,5-bis(Trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-1,7-diazaspiro(4.5)decan-2-one monohydrochloride monohydrate, (5S,8S)-8-({(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}methyl)-2-oxo-8-phenyl-1,7-diazaspiro[4.5]decan-7-ium chloride--water (1/1), (5S,8S)-8-({(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}methyl)-8-phenyl-1,7-diazaspiro[4.5]decan-2-one hydrochloride--water (1/1), Rolapitant HCl, Rolapitant hydrochloride, rolapitant monohydrochloride monohydrate, rolapitant.HCl.H2O, Sch 619734, SCH619734, VARUBI
Definition: A hydrate that is the monohydrate form of rolapitant hydrochloride. Used for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
Ontology: ChEBI [CHEBI:90911]  ( EBI )

Relationships
is a type of: hydrate
has_part: rolapitant hydrochloride (anhydrous)
has_role: antiemetic neurokinin-1 receptor antagonist